Prostate-specific membrane antigen (PSMA), a type II transmembrane protein,
was originally thought to be strictly expressed in prostatic tissue, but r
ecent studies have demonstrated PSMA protein expression in nonprostatic tum
or neovasculature as well. Using immunohistochemistry, reverse transcriptio
n-PCR assays, and in situ hybridization, we have demonstrated PSMA mRNA tra
nscripts and protein expression in the endothelium of tumor-associated neov
asculature of multiple nonprostatic solid malignancies. In addition, we fou
nd no PSMA mRNA or protein expression in the vascular endothelial cells of
corresponding benign tissue examples. Our findings expand the possible ther
apeutic role of PSMA and establish it as a unique biomarker specifically pr
oduced and expressed by tumor-associated neovasculature but not produced or
expressed by normal vessels.